Free Trial

SeaStar Medical (ICU) Competitors

SeaStar Medical logo
$2.06 +0.02 (+0.98%)
(As of 12/20/2024 05:45 PM ET)

ICU vs. STIM, NXGL, POCI, BSGM, IRIX, FEMY, VVOS, CODX, DRIO, and ALUR

Should you be buying SeaStar Medical stock or one of its competitors? The main competitors of SeaStar Medical include Neuronetics (STIM), NEXGEL (NXGL), Precision Optics (POCI), BioSig Technologies (BSGM), IRIDEX (IRIX), Femasys (FEMY), Vivos Therapeutics (VVOS), Co-Diagnostics (CODX), DarioHealth (DRIO), and Allurion Technologies (ALUR). These companies are all part of the "medical equipment" industry.

SeaStar Medical vs.

SeaStar Medical (NASDAQ:ICU) and Neuronetics (NASDAQ:STIM) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, media sentiment, profitability, community ranking, dividends and analyst recommendations.

SeaStar Medical has a beta of -1.13, meaning that its stock price is 213% less volatile than the S&P 500. Comparatively, Neuronetics has a beta of 2.25, meaning that its stock price is 125% more volatile than the S&P 500.

Neuronetics has a consensus price target of $4.67, indicating a potential upside of 235.73%. Given Neuronetics' stronger consensus rating and higher probable upside, analysts plainly believe Neuronetics is more favorable than SeaStar Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SeaStar Medical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Neuronetics
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.75

SeaStar Medical has a net margin of 0.00% compared to Neuronetics' net margin of -50.09%. SeaStar Medical's return on equity of 0.00% beat Neuronetics' return on equity.

Company Net Margins Return on Equity Return on Assets
SeaStar MedicalN/A N/A -627.49%
Neuronetics -50.09%-141.24%-32.77%

1.7% of SeaStar Medical shares are held by institutional investors. Comparatively, 53.6% of Neuronetics shares are held by institutional investors. 2.1% of SeaStar Medical shares are held by company insiders. Comparatively, 9.8% of Neuronetics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

SeaStar Medical has higher earnings, but lower revenue than Neuronetics. Neuronetics is trading at a lower price-to-earnings ratio than SeaStar Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SeaStar Medical$68K135.20-$26.23M-$11.63-0.18
Neuronetics$72.71M0.58-$30.19M-$1.23-1.13

In the previous week, Neuronetics had 3 more articles in the media than SeaStar Medical. MarketBeat recorded 3 mentions for Neuronetics and 0 mentions for SeaStar Medical. Neuronetics' average media sentiment score of 0.31 beat SeaStar Medical's score of 0.00 indicating that Neuronetics is being referred to more favorably in the news media.

Company Overall Sentiment
SeaStar Medical Neutral
Neuronetics Neutral

Neuronetics received 127 more outperform votes than SeaStar Medical when rated by MarketBeat users. However, 100.00% of users gave SeaStar Medical an outperform vote while only 68.45% of users gave Neuronetics an outperform vote.

CompanyUnderperformOutperform
SeaStar MedicalOutperform Votes
1
100.00%
Underperform Votes
No Votes
NeuroneticsOutperform Votes
128
68.45%
Underperform Votes
59
31.55%

Summary

Neuronetics beats SeaStar Medical on 12 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ICU vs. The Competition

MetricSeaStar MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$9.19M$4.34B$5.14B$9.08B
Dividend YieldN/A44.57%5.09%4.23%
P/E Ratio-0.1825.3790.0517.18
Price / Sales135.2045.921,117.14116.99
Price / CashN/A43.4443.0437.86
Price / Book-0.337.094.784.78
Net Income-$26.23M$13.64M$120.31M$225.60M
7 Day Performance3.52%-2.93%-1.92%-1.23%
1 Month Performance-6.36%0.28%11.51%3.36%
1 Year Performance-81.58%40.76%30.61%16.60%

SeaStar Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ICU
SeaStar Medical
0.1027 of 5 stars
$2.06
+1.0%
N/A-82.0%$9.19M$68,000.00-0.182
STIM
Neuronetics
2.9294 of 5 stars
$1.11
-0.9%
$4.67
+320.4%
-47.5%$33.69M$71.35M-0.91180News Coverage
NXGL
NEXGEL
0.6541 of 5 stars
$4.93
+4.7%
N/A+125.2%$33.48M$6.73M-8.1210Positive News
High Trading Volume
POCI
Precision Optics
N/A$5.00
-2.0%
N/A-16.2%$31.75M$19.10M0.0080High Trading Volume
BSGM
BioSig Technologies
1.2184 of 5 stars
$1.68
+14.3%
$2.75
+63.7%
-69.0%$28.96M$39,000.000.0050
IRIX
IRIDEX
0.3474 of 5 stars
$1.71
-0.6%
$2.00
+17.0%
-37.2%$28.45M$48.43M-2.57120Analyst Forecast
News Coverage
FEMY
Femasys
2.1386 of 5 stars
$1.18
-0.8%
$10.00
+747.5%
+23.4%$27.02M$1.26M-1.4730
VVOS
Vivos Therapeutics
2.8401 of 5 stars
$5.30
+15.0%
$6.30
+18.9%
-59.0%$25.65M$13.80M-0.81160Positive News
CODX
Co-Diagnostics
3.8281 of 5 stars
$0.80
-4.0%
$1.50
+87.8%
-38.1%$25.51M$7.32M-0.60100
DRIO
DarioHealth
2.2551 of 5 stars
$0.73
-0.2%
$4.00
+447.6%
-50.9%$24.91M$23.05M-0.78200News Coverage
Positive News
ALUR
Allurion Technologies
2.0377 of 5 stars
$0.32
-7.2%
$2.88
+796.5%
-89.7%$20.64M$34.75M-0.67501Gap Up

Related Companies and Tools


This page (NASDAQ:ICU) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners